pralidoxime structure
|
Common Name | pralidoxime | ||
---|---|---|---|---|
CAS Number | 6735-59-7 | Molecular Weight | 137.15900 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C7H9N2O+ | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of pralidoximePralidoxime is a potent reactivator of acetylcholinesterase (AChE). Pralidoxime reactivates nerve agent-inhibited AChE via direct nucleophilic attack by the oxime moiety on the phosphorus center of the bound nerve agent. Pralidoxime is an antidote for organophosphate poisoning[1][2]. |
Name | pralidoxime |
---|---|
Synonym | More Synonyms |
Description | Pralidoxime is a potent reactivator of acetylcholinesterase (AChE). Pralidoxime reactivates nerve agent-inhibited AChE via direct nucleophilic attack by the oxime moiety on the phosphorus center of the bound nerve agent. Pralidoxime is an antidote for organophosphate poisoning[1][2]. |
---|---|
Related Catalog | |
Target |
Acetylcholinesterase |
In Vivo | Pralidoxime (10-150 mg/kg; intramuscular administration, once) reverses paraoxon-induced respiratory toxicity in mice[3]. Animal Model: F1B6D2 mice (male, administered subcutaneously diethylparaoxon)[3] Dosage: 10, 50, 100, and 150 mg/kg Administration: Intramuscular administration, once Result: Induced a partial, albeit complete, reversal of respiratory toxicity at 50 mg/kg, and completely reversed diethylparaoxon-induced respiratory toxicity in mice at 150 mg/kg. |
References |
[2]. Eyer P, Buckley N. Pralidoxime for organophosphate poisoning. Lancet. 2006;368(9553):2110‐2111. |
Molecular Formula | C7H9N2O+ |
---|---|
Molecular Weight | 137.15900 |
Exact Mass | 137.07100 |
PSA | 36.47000 |
LogP | 0.31920 |
Conthrathion |
2-(hydroxyimino-methyl)-1-methyl-pyridinium |
PRALIDOXIME |
N-Methyl-2-pyridyl-aldoxim-hydroxid |
2-PAM |
2-(Hydroxyiminomethyl)-1-methylpyridinium |
2-(hydroximinomethyl)-1-methylpyridinium cation |
(2-Hydroxyimino-methyl)-1-methyl-pyridinium |